Celcuity (CELC) Tax Rate (2018 - 2020)
Celcuity's (CELC) quarterly Tax Rate came in at 78.01% in Q4 2020, down 739.0% YoY from 12.21% in Q1 2020, and down 8.66% on a QoQ basis from 85.41% in Q4 2019.
Analysis
Celcuity (CELC) Tax Rate (2018 - 2020) Analysis & Trends
Celcuity (CELC) has 3 years of Tax Rate data on file, last reported at 78.01% in Q4 2020.
- Quarterly Tax Rate fell 739.0% year-over-year to 78.01% in Q4 2020, while the trailing twelve-month figure through Jun 2021 was 9.11% (down 964.0% YoY) and the FY2025 annual result came in at 21.0%, up 2160.0% from the prior year.
- Tax Rate slipped to 78.01% in Q4 2020, from 85.41% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 86.07% in Q4 2018 to a low of 78.01% in Q4 2020.
- A 3-year average of 83.16% and a median of 85.41% in 2019 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2019 — Tax Rate slumped 66 bps — and 2020, when it slumped 739 bps.
- Tracing CELC's Tax Rate over 3 years: stood at 86.07% in 2018, then slipped by 1 bps to 85.41% in 2019, then fell by 9 bps to 78.01% in 2020.
- The last three Tax Rate figures came in at 78.01% (Q4 2020), 85.41% (Q4 2019), and 86.07% (Q4 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | - |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | - |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -16.71% |
| 10 | Celcuity | 5.19 Bn | 5.19 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 78.01% |
| Dec 31, 2019 | 85.41% |
| Dec 31, 2018 | 86.07% |